Overall, this paclitaxel/vitamin C derivative composite nanoparticle system enhanced the therapeutic tumor suppression of PTX via a synergistic effect that reduces the Bcl-2/Bax ratio accompanied by promoting tubulin polymerization. Here, BCL2 is linked to neoplasm.